Literature DB >> 33337526

Gender incongruence and gender dysphoria in childhood and adolescence-current insights in diagnostics, management, and follow-up.

Hedi Claahsen-van der Grinten1, Chris Verhaak2, Thomas Steensma3, Tim Middelberg4, Joep Roeffen5, Daniel Klink6.   

Abstract

Gender incongruence (GI) is defined as a condition in which the gender identity of a person does not align with the gender assigned at birth. Awareness and more social acceptance have paved the way for early medical intervention about two decades ago and are now part of good clinical practice although much robust data is lacking. Medical and mental treatment in adolescents with GI is complex and is recommended to take place within a team of mental health professionals, psychiatrists, endocrinologists, and other healthcare providers. The somatic treatment generally consists of the use of GnRH analogues to prevent the progression of biological puberty and subsequently gender-affirming hormonal treatment to develop sex characteristics of the self-identified gender and surgical procedures. However to optimize treatment regimens, long-term follow-up and additional studies are still needed. What is known • The prevalence of gender dysphoria increased significantly in the past years and can lead to significant complaints and burdens especially during puberty. • Pubertal suppression and gender-affirmed treatment can be effectively used in adolescence with gender dysphoria. What is new • Transgender mental and medical healthcare is a long-lasting process during which not only the child/adolescent with GI but also their parents/family have to be counseled in making choices about their social, medical, and legal transitions. • There are an increasing number of transgender persons defining as nonbinary. Therefore, an individualized approach by an experienced team is necessary.

Entities:  

Keywords:  Gender dysphoria; Gender incongruence; Gender-affirming treatment; Pubertal suppression; Transgender care

Year:  2020        PMID: 33337526     DOI: 10.1007/s00431-020-03906-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  1 in total

1.  Efficacy and Safety of Pubertal Induction Using 17β-Estradiol in Transgirls.

Authors:  Sabine E Hannema; Sebastian E E Schagen; Peggy T Cohen-Kettenis; Henriette A Delemarre-van de Waal
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

  1 in total
  2 in total

1.  Greater gender diversity among autistic children by self-report and parent-report.

Authors:  Blythe A Corbett; Rachael A Muscatello; Mark E Klemencic; Millicent West; Ahra Kim; John F Strang
Journal:  Autism       Date:  2022-04-01

2.  Approach to the Patient: Pharmacological Management of Trans and Gender-Diverse Adolescents.

Authors:  Michele A O'Connell; Thomas P Nguyen; Astrid Ahler; S Rachel Skinner; Ken C Pang
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.